No Data
No Data
China United Network Communications and Alibaba have signed a Global Strategy cooperation agreement.
Sina Technology reported on the evening of March 28 that China United Network Communications and Alibaba held a strategic cooperation signing ceremony in Hangzhou. The chairman of China United Network Communications, Chen Zhongyue, and the CEO of Alibaba Group, Wu Yongming, witnessed the signing. The vice president of China United Network Communications, Tang Yongbo, and the president of Alibaba's public affairs, Wen Jia, signed the agreement on behalf of both parties, with the vice president of China United Network Communications, Hao Liqian, and others attending the signing ceremony. According to the agreement, both parties will carry out in-depth cooperation in areas such as intelligent computing infrastructure, network intelligent Operation, cloud market, AI smart terminals, and industrial intelligent upgrades, promoting the technology of China United Network Communications' "Meta-Scene" and Alibaba's "Tongyi Qianwen" AI model.
Overview of the lifting of restrictions on A-shares by Zhizhong | March 6.
According to Zhigong Finance APP, on March 6th, a total of four listed companies had their restricted stocks released, with a total market value of approximately 0.141 billion yuan. The specific details of the restricted stock release today are as follows: Stock abbreviation Stock code Type of restricted stock Released shares Shanghai Foreign Service Holdinggroup 600662 Stock-based Incentive Restricted circulation 0.298 million New Journey Health Technology Group 002219 Stock-based Incentive Restricted circulation 35.2785 million Royal Group Co.,Ltd. 002329 Stock-based Incentive Restricted circulation 9.4228 million Zhongyin Babi Food 605338 Stock-based Incentive Restricted circulation 0.5942 million.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Returns At New Journey Health Technology GroupLTD (SZSE:002219) Are On The Way Up
One of the most challenging things in large models is open source data.
新浪科技讯 On February 24, during the 2025 Global Developer Pioneer Conference, the Chairman of the Board of Trustees of Hong Kong University of Science and Technology, Foreign Member of the National Academy of Engineering of the USA, Shen Xiangyang, pointed out in a sharing session that, "For large models, the previous research focus was on the GPT model, and now the focus is on the Reasoner model, which is a new learning paradigm." Shen Xiangyang believes that the GPT model is a form of "fast thinking," mainly predicting the "next token" driven by data. The Reasoner model emphasizes task completion, allowing for repeated trial and error and correction, making it closer to human "slow thinking." This new model.
Strong Week for New Journey Health Technology GroupLTD (SZSE:002219) Shareholders Doesn't Alleviate Pain of Three-year Loss